Literature DB >> 32706090

CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.

N Zhang1, Y-D Zhao, X-M Wang.   

Abstract

OBJECTIVE: The specific mechanism of cytokine storm in COVID-19 infected patients is not clear. This study aims to identify the key genes that cause cytokine storm in COVID-19 infected patients.
MATERIALS AND METHODS: We conducted a difference analysis on the GSE147507 data set. The analysis results are combined with immune genes to obtain immune-related genes among the differential genes. Finally, GO enrichment analysis, PPI analysis, core gene identification, and ssGSEA enrichment analysis were performed on the new gene set.
RESULTS: A total of 232 differential genes were screened out. After merging with immune genes, a total of 29 immune-related genes were obtained. Further analysis revealed that the genes were enriched in 16 pathways, and the protein interaction network had a total of 29 nodes and 139 edges. After screening, the core gene was CXCL10. The ssGSEA results of CXCL10 showed that CD4 and CD8 immune-related signature were significantly enriched in high CXCL10 expression, and the samples with low CXCL10 expression were significantly enriched with monocytes and DC immune-related signature.
CONCLUSIONS: CXCL10 may be a key gene related to the cytokine storm of COVID-19 infection, and it is expected to become the therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32706090     DOI: 10.26355/eurrev_202007_21922

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  13 in total

Review 1.  Associations and Disease-Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review.

Authors:  Altijana Hromić-Jahjefendić; Debmalya Barh; Cecília Horta Ramalho Pinto; Lucas Gabriel Rodrigues Gomes; Jéssica Lígia Picanço Machado; Oladapo Olawale Afolabi; Sandeep Tiwari; Alaa A A Aljabali; Murtaza M Tambuwala; Ángel Serrano-Aroca; Elrashdy M Redwan; Vladimir N Uversky; Kenneth Lundstrom
Journal:  Viruses       Date:  2022-04-27       Impact factor: 5.818

2.  Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2.

Authors:  Sudhanshu Agrawal; Jon Salazar; Thu Michelle Tran; Anshu Agrawal
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 7.561

3.  Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19.

Authors:  Michael Müller; Johann Volzke; Behnam Subin; Christian Johann Schmidt; Hilte Geerdes-Fenge; Emil Christian Reisinger; Brigitte Müller-Hilke
Journal:  Viruses       Date:  2022-01-20       Impact factor: 5.048

4.  A Study of IFN-α-Induced Chemokines CCL2, CXCL10 and CCL19 in Patients with Systemic Lupus Erythematosu.

Authors:  Mariela Gencheva Geneva-Popova; Stanislava Dimitrova Popova-Belova; Petya Nikolova Gardzheva; Krasimir Iliev Kraev
Journal:  Life (Basel)       Date:  2022-02-08

5.  Pro-inflammatory immune profile mediated by TNF and IFN-γ and regulated by IL-10 is associated to IgG anti-SARS-CoV-2 in asymptomatic blood donors.

Authors:  Daniel Gonçalves Chaves; Leonardo Camilo de Oliveira; Maria Clara Fernandes da Silva Malta; Isabelle Rocha de Oliveira; Edel Figueiredo Barbosa-Stancioli; Mauro Martins Teixeira; Marina Lobato Martins
Journal:  Cytokine       Date:  2022-04-04       Impact factor: 3.926

Review 6.  Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19.

Authors:  Dana R Julian; Megan A Kazakoff; Akhil Patel; Jesse Jaynes; Monte S Willis; Cecelia C Yates
Journal:  Curr Pathobiol Rep       Date:  2021-12-08

7.  Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.

Authors:  Fee Faysal Ahmed; Md Selim Reza; Md Shahin Sarker; Md Samiul Islam; Md Parvez Mosharaf; Sohel Hasan; Md Nurul Haque Mollah
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

8.  Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia.

Authors:  Marina Mantzourani; George P Chrousos; Styliani A Geronikolou; Işil Takan; Athanasia Pavlopoulou
Journal:  Int J Mol Med       Date:  2022-01-21       Impact factor: 4.101

9.  Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.

Authors:  Md Parvez Mosharaf; Md Selim Reza; Md Kaderi Kibria; Fee Faysal Ahmed; Md Hadiul Kabir; Sohel Hasan; Md Nurul Haque Mollah
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

10.  Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.

Authors:  Resmi Ravindran; Cindy McReynolds; Jun Yang; Bruce D Hammock; Aamer Ikram; Amna Ali; Adnan Bashir; Tanzeel Zohra; W L William Chang; Dennis J Hartigan-O'Connor; Hooman H Rashidi; Imran H Khan
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.